PACLIEVA 260 MG (Paclitaxel Injection 260 mg) is a prescription anticancer medicine containing Paclitaxel 260 mg, a chemotherapy agent belonging to the Taxane class of anticancer drugs. Paclitaxel is widely used in the treatment of various cancers by interfering with cancer cell division and preventing tumor growth and spread.

Paclitaxel works by stabilizing microtubules within cancer cells, preventing their normal breakdown during cell division. This action disrupts mitosis, inhibits cancer cell replication, and ultimately leads to cancer cell death. Due to its established efficacy, Paclitaxel has become an important component of modern oncology treatment protocols worldwide.

PACLIEVA 260 MG is commonly prescribed for the treatment of breast cancer, ovarian cancer, non-small cell lung cancer (NSCLC), Kaposi’s sarcoma, and other advanced solid tumors. It may be used alone or in combination with other anticancer medicines depending on the patient's diagnosis and treatment plan.

The medicine is administered intravenously under the supervision of qualified healthcare professionals experienced in oncology treatment.

PACLIEVA 260 MG is commonly used for:

• Breast Cancer
• Ovarian Cancer
• Non-Small Cell Lung Cancer (NSCLC)
• Advanced Ovarian Cancer
• Metastatic Breast Cancer
• Kaposi’s Sarcoma
• Advanced Solid Tumors
• Combination Chemotherapy Programs

Manufactured according to stringent pharmaceutical quality standards, PACLIEVA 260 MG is designed to provide consistent quality, safety, and therapeutic effectiveness.

Patients receiving Paclitaxel therapy require regular monitoring of blood counts, liver function, and overall health status throughout treatment.

Due to its broad clinical applications and proven effectiveness, PACLIEVA 260 MG remains an important medicine in modern cancer management.

PACLIEVA 260 MG (Paclitaxel Injection 260 mg) is primarily used in the treatment and management of various cancers.

Common Uses of PACLIEVA 260 MG

1. Breast Cancer

Paclitaxel is widely used in early-stage, locally advanced, and metastatic breast cancer treatment.

2. Ovarian Cancer

The medicine is commonly prescribed for advanced and recurrent ovarian cancer.

3. Non-Small Cell Lung Cancer (NSCLC)

Paclitaxel is used as part of established chemotherapy regimens for lung cancer treatment.

4. Kaposi’s Sarcoma

The medicine may be used in the treatment of AIDS-related Kaposi’s sarcoma.

5. Advanced Solid Tumors

Doctors may prescribe Paclitaxel for various advanced cancers based on clinical requirements.

6. Combination Chemotherapy

Paclitaxel is frequently administered alongside other anticancer medicines to improve treatment outcomes.

7. Oncology Treatment Programs

The medicine is incorporated into internationally recognized cancer treatment protocols.

How PACLIEVA 260 MG Works

Paclitaxel belongs to a class of medicines known as Taxane Anticancer Agents.

PACLIEVA works by:

• Stabilizing microtubules within cancer cells
• Preventing normal cell division
• Blocking mitosis (cell replication)
• Inhibiting tumor growth
• Triggering cancer cell death
• Slowing disease progression

This mechanism helps control cancer development and supports effective disease management.

Like all medicines, PACLIEVA 260 MG may cause side effects in some patients. The severity and frequency of side effects vary among individuals.

Common Side Effects

1. Low Blood Cell Counts

Reduction in white blood cells, red blood cells, and platelets may occur.

2. Hair Loss (Alopecia)

Temporary hair loss is a common side effect during treatment.

3. Fatigue

Weakness and tiredness are frequently reported.

4. Nausea and Vomiting

Digestive discomfort may develop during therapy.

5. Peripheral Neuropathy

Numbness, tingling, or pain in the hands and feet may occur.

6. Muscle and Joint Pain

Some patients may experience musculoskeletal discomfort.

7. Diarrhea

Digestive disturbances may occur during treatment.

8. Mouth Sores

Inflammation or ulcers inside the mouth may develop.

9. Increased Risk of Infection

Reduced white blood cell counts may increase susceptibility to infections.

Serious Side Effects

Seek immediate medical attention if you experience:

• Severe allergic reactions
• Persistent fever
• Serious infections
• Difficulty breathing
• Severe neuropathy
• Significant bleeding or bruising
• Severe bone marrow suppression
• Liver-related complications
• Severe gastrointestinal symptoms

Patients should contact their healthcare provider immediately if serious symptoms occur.

The dosage of PACLIEVA 260 MG (Paclitaxel Injection 260 mg) should always be determined by a qualified oncologist.

Factors Affecting Dosage

1. Type of Cancer

Treatment recommendations vary according to the disease being treated.

2. Body Surface Area (BSA)

Dosage is generally calculated according to body surface area.

3. Liver Function

Hepatic function plays an important role in treatment planning.

4. Blood Test Results

Laboratory monitoring helps guide dosage decisions.

5. Combination Therapy

Concurrent anticancer medicines may influence treatment schedules.

Important Dosage Instructions

• The medicine should only be administered by qualified healthcare professionals.
• Follow all scheduled chemotherapy sessions.
• Attend routine blood tests and monitoring appointments.
• Inform your doctor about numbness, tingling, or unusual symptoms.
• Maintain adequate hydration and nutrition.
• Do not miss oncology follow-up visits.

Precautions Before Using PACLIEVA 260 MG

Before starting treatment, inform your doctor if you have:

• Liver disease
• Blood disorders
• Peripheral neuropathy
• Active infections
• Previous chemotherapy-related complications
• Allergies to Paclitaxel or related medicines

Important Monitoring Requirements

Patients receiving Paclitaxel therapy may require:

• Complete blood count monitoring
• Liver function tests
• Neurological assessments
• Regular clinical evaluations

Patients should also disclose all prescription medicines, supplements, vitamins, and herbal products they are taking to avoid potential drug interactions.

Pregnant and breastfeeding women should not use this medicine unless specifically advised by a healthcare professional.

Storage Instructions

• Store according to manufacturer recommendations.
• Protect from excessive heat and direct sunlight.
• Keep out of reach of children.
• Handle under appropriate pharmaceutical conditions.

Why Choose PACLIEVA 260 MG?

• Contains high-quality Paclitaxel 260 mg
• Effective taxane-based anticancer therapy
• Widely used in breast, ovarian, and lung cancer treatment
• Suitable for combination chemotherapy regimens
• Manufactured under strict pharmaceutical quality standards
• Reliable therapeutic performance
• Supports modern oncology treatment protocols
• Designed for advanced cancer management

Frequently Asked Questions (FAQs)

What is PACLIEVA 260 MG used for?

It is used for the treatment of breast cancer, ovarian cancer, non-small cell lung cancer, Kaposi’s sarcoma, and other advanced solid tumors.

What is Paclitaxel?

Paclitaxel is a taxane-based chemotherapy medicine that prevents cancer cells from dividing and multiplying.

Is PACLIEVA 260 MG chemotherapy?

Yes. Paclitaxel is a widely used chemotherapy agent in oncology.

Does PACLIEVA 260 MG cause hair loss?

Yes. Temporary hair loss is a common side effect during treatment.

Can PACLIEVA 260 MG cause nerve-related side effects?

Yes. Peripheral neuropathy, including numbness and tingling in the hands and feet, may occur.

Does PACLIEVA 260 MG affect blood counts?

Yes. The medicine may lower white blood cells, red blood cells, and platelet counts.

Is monitoring necessary during treatment?

Yes. Regular blood tests and medical evaluations are important throughout therapy.

Should PACLIEVA 260 MG be administered under medical supervision?

Yes. This medicine should only be administered by qualified healthcare professionals experienced in oncology treatment.